In silico Study of Antiviral Phytochemicals for the Potential Drug Development Against Wild-type and Omicron Variants of SARS-CoV-2

We have found some potential Phytochemicals that can be used against different variants of SARS-CoV-2 such as silymarin.

Authors

Institutions

Publication Details

Journal
Current Pharmaceutical Biotechnology
Published
2025-02-12
DOI
https://doi.org/10.2174/0113892010251819241120050831
Citations
2
Primary Topic
Silymarin and Mushroom Poisoning
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In silico Study of Antiviral Phytochemicals for the Potential Drug Development Against Wild-type and Omicron Variants of SARS-CoV-2

Somenath Dutta, Manisha Pritam, Shilpa Sri Pushan, Rohan Ghosh et al.
2 citations
Current Pharmaceutical Biotechnology
Silymarin and Mushroom Poisoning
3.04
article

In silico Study of Antiviral Phytochemicals for the Potential Drug Development Against Wild-type and Omicron Variants of SARS-CoV-2

Somenath Dutta, Manisha Pritam, Shilpa Sri Pushan, Rohan Ghosh, María José
article en
2 citations

Abstract

We have found some potential Phytochemicals that can be used against different variants of SARS-CoV-2 such as silymarin.

Current Pharmaceutical BiotechnologyVol. 27(2)
Pondicherry University (IN), Birla Institute of Scientific Research (IN), National Institute of Allergy and Infectious Diseases (US), Pusan National University (KR)
Good health and well-being
Openalex Percentile: Top 11%
Silymarin and Mushroom Poisoning
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.